WhaleCreepWhat the best hedge funds own, from their SEC 13F filings
HomeStocks › VRTX

Which hedge funds own VRTX? VERTEX PHARMACEUTICALS INC, Q2 2026 13F holders

Healthcare · Open on the interactive board

16 of the hedge funds tracked by WhaleCreep disclosed a position in VRTX (VERTEX PHARMACEUTICALS INC) in their Q2 2026 13F filings, worth $1.8bn in total. The largest holder by portfolio weight is Tweedy Browne at 1.5% of its book. 2 managers opened a new position this quarter: Tudor Investment, Point72 Asset Management LP.

16tracked managers holding
2opened this quarter
0exited this quarter

Which hedge funds hold VRTX? Current holders by portfolio weight

ManagerAs ofWeight of bookValueSharesΔ sharesAction
Tweedy BrowneQ2 2026 1.5%$19.9m40,121 -1% reduced
WCM Investment ManagementQ2 2026 0.8%$575.6m1,152,094 3% added
Marshall WaceQ2 2026 0.2%$270.2m543,897 72% added
Renaissance Technologies LLCQ2 2026 0.2%$159.0m320,008 -24% reduced
Woodline PartnersQ2 2026 0.2%$69.7m140,288 4% added
Baillie GiffordQ2 2026 0.2%$149.8m272,561 37% added
Millennium ManagementQ2 2026 0.2%$232.7m468,410 1420% added
Citadel AdvisorsQ2 2026 0.1%$253.5m510,430 50% added
Brevan Howard Capital ManagementQ2 2026 0.1%$8.8m17,622 459% added
Tudor InvestmentQ2 2026 0.1%$15.0m30,176 new
Bridgewater AssociatesQ2 2026 0.0%$5.4m10,865 -19% reduced
Holocene AdvisorsQ2 2026 0.0%$6.2m12,384 -82% reduced
Ancora AdvisorsQ2 2026 0.0%$560.0k1,127 7% added
Point72 Asset Management LPQ2 2026 0.0%$1.3m2,625 new
First ManhattanQ2 2026 0.0%$774.9k1,560 0% held
D. E. Shaw & CoQ2 2026 0.0%$1.5m3,105 -99% reduced

Held in a manager's last filing on record

These managers have not filed for the latest quarter; their last disclosure is dated.

ManagerLast filingWeight
Boston OmahaQ4 20240.0%

How has hedge fund ownership of VRTX changed?

QuarterManagers holdingCombined value
Q2 202616$1.8bn
Q1 202614$1.3bn
Q4 202510$932.7m
Q3 20259$956.5m
Q2 20259$1.2bn
Q1 20258$1.3bn
Q4 202411$1.2bn
Q3 202410$1.0bn
Q2 20249$890.5m
Q1 20249$767.7m
Q4 202312$804.8m
Q3 202311$775.3m
Q2 20236$597.7m
Q1 20235$586.9m
Q4 20228$763.7m
Q3 20227$848.4m

Counts every tracked manager that disclosed VRTX in that quarter's filing, including managers that have since stopped filing.